Bank of New York Mellon Corp boosted its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 4.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,304,769 shares of the company's stock after buying an additional 342,715 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.54% of Keurig Dr Pepper worth $234,629,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. IFP Advisors Inc increased its position in shares of Keurig Dr Pepper by 17.6% during the fourth quarter. IFP Advisors Inc now owns 2,887 shares of the company's stock worth $96,000 after acquiring an additional 433 shares during the period. RWC Asset Management LLP grew its stake in Keurig Dr Pepper by 34.6% in the fourth quarter. RWC Asset Management LLP now owns 1,553,095 shares of the company's stock worth $49,885,000 after purchasing an additional 398,916 shares in the last quarter. World Equity Group Inc. increased its holdings in Keurig Dr Pepper by 102.4% during the 4th quarter. World Equity Group Inc. now owns 21,932 shares of the company's stock worth $704,000 after purchasing an additional 11,097 shares during the period. Forvis Mazars Wealth Advisors LLC raised its position in Keurig Dr Pepper by 23.1% during the 4th quarter. Forvis Mazars Wealth Advisors LLC now owns 29,237 shares of the company's stock valued at $939,000 after purchasing an additional 5,494 shares in the last quarter. Finally, Howard Capital Management Inc. lifted its holdings in shares of Keurig Dr Pepper by 3.1% in the 4th quarter. Howard Capital Management Inc. now owns 25,993 shares of the company's stock worth $835,000 after buying an additional 787 shares during the period. 93.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft upgraded Keurig Dr Pepper from a "hold" rating to a "buy" rating and raised their price target for the company from $37.00 to $39.00 in a research note on Thursday, December 12th. Wells Fargo & Company reissued an "overweight" rating on shares of Keurig Dr Pepper in a research report on Tuesday, February 25th. JPMorgan Chase & Co. boosted their price target on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. TD Cowen dropped their price objective on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating on the stock in a research note on Wednesday, January 8th. Finally, UBS Group reissued a "buy" rating on shares of Keurig Dr Pepper in a report on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and a consensus price target of $38.23.
Check Out Our Latest Report on Keurig Dr Pepper
Insider Transactions at Keurig Dr Pepper
In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 83,950,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $32.65, for a total transaction of $2,740,967,500.00. Following the completion of the sale, the insider now directly owns 134,113,479 shares in the company, valued at approximately $4,378,805,089.35. The trade was a 38.50 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.00% of the company's stock.
Keurig Dr Pepper Stock Up 1.8 %
NASDAQ KDP traded up $0.62 on Monday, hitting $34.14. The stock had a trading volume of 13,656,826 shares, compared to its average volume of 9,168,558. The business's fifty day moving average price is $31.93 and its 200 day moving average price is $33.91. The stock has a market cap of $46.32 billion, a price-to-earnings ratio of 20.69, a price-to-earnings-growth ratio of 2.42 and a beta of 0.61. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. Keurig Dr Pepper Inc. has a 52-week low of $28.62 and a 52-week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.57 by $0.01. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $4.07 billion during the quarter, compared to analysts' expectations of $4.01 billion. During the same quarter last year, the firm earned $0.55 EPS. The business's quarterly revenue was up 5.2% on a year-over-year basis. Equities research analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.23 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.92 annualized dividend and a dividend yield of 2.70%. Keurig Dr Pepper's payout ratio is currently 87.62%.
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.